Compass Therapeutics Inc (CMPX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | N/A | -1440 | -822.222 | -113.647 | -79.916 | -22.199 | -23.838 |
Return on Equity (%) | 205.882 | 68.571 | 41.341 | -148.104 | -91.301 | -24.385 | -25.74 |
Return on Invested Capital (%) | 205.882 | 62.857 | 35.754 | -135.422 | -90.484 | -25.947 | -30.566 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | -0.008 | -0.014 | -0.022 | 0.78 | 1.383 | 1.438 | 1.165 |
Earnings Per Share | -0.008 | -0.007 | -0.007 | -0.576 | -0.811 | -0.311 | -0.333 |
Cash Per Share | N/A | 0.001 | 0.001 | 0.919 | 1.427 | 0.277 | 0.19 |
Working Capital Per Share | -0.008 | -0.014 | -0.022 | 0.783 | 1.347 | 1.414 | 1.146 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.008 | -0.007 | -0.007 | -0.575 | -0.811 | -0.311 | -0.333 |
EBITDA Per Share | -0.008 | -0.007 | -0.007 | -0.575 | -0.811 | -0.311 | -0.333 |
Free Cash Flow Per Share | -0.008 | -0.007 | -0.007 | -0.621 | -0.801 | -0.315 | -0.339 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 4,17M | 5M | 5M | 51,22M | 101,3M | 126,3M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | 126,3M | N/A | 127,46M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 426,53M |
Ratio cours/bénéfice | -8,55 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 14,99 |
Ratio prix/valeur comptable | 2,45 |
Rendement de dividende | - |
Actions en circulation | 137,59M |
Volume moyen (1 semaine) | 998,36k |
Volume moyen (1 mois) | 2,66M |
Variation sur 52 semaines | 84,03% |
Plus haut sur 52 semaines | 2,73 |
Plus bas sur 52 semaines | 0,765 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales